Physician profile
Jonathan E Farmer
NPI 1831948710
$1,703.52
in general payments reported to CMS, 2019-2025
23 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $487 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $264.75 | 2024-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals Lp | $170.01 | 2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $148.69 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.80 | 2024-2025 | Jardiance, Tradjenta, Synjardy |
| E.R. Squibb & Sons, L.L.C. | $133.58 | 2024-2025 | Eliquis |
| Novo Nordisk INC | $105.21 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $97.80 | 2025 | |
| Glaxosmithkline, LLC. | $65.62 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $65.01 | 2025 | |
| Exact Sciences Corporation | $64.11 | 2024-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $56.85 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $55.14 | 2024-2025 | Voquezna |
| Insulet Corporation | $46.25 | 2025 | Omnipod |
| Corcept Therapeutics | $45.66 | 2025 | Korlym |
| Pfizer INC. | $39.24 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $38.32 | 2025 | Freestyle Libre 3 |
| Philips North America LLC | $34.57 | 2024 | (Ck7) Extended Holter |
| Abbvie INC. | $29.26 | 2025 | |
| Boston Scientific Corporation | $24.98 | 2024 | Wavewriter Alpha Prime 16 |
| Mylan Specialty L.P. | $21.55 | 2024 | Yupelri |
| Merck Sharp & Dohme LLC | $21.21 | 2024 | |
| Esperion Therapeutics, INC. | $20.49 | 2024 | Nexletol |
| Astellas Pharma US INC | $20.42 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.